Gender associated differences in outcome after neoadjuvant chemoradiotherapy for rectal cancer

被引：0
|
作者：
Meltzer, S. [1 ]
Bakke, K. M. [1 ]
Rod, K. L. [2 ]
Dueland, S. [3 ]
Flatmark, K. [4 ]
Kristensen, A. T. [4 ]
Larsen, F. O. [5 ]
Schou, J. V. [5 ]
Fuglestad, A. J. [6 ]
Kersten, C. [6 ]
Redalen, K. R. [2 ]
Ree, A. H. [7 ]
机构：
[1] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway
[2] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway
[3] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[4] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway
[5] Herlev & Gentofte Hosp, Dept Oncol, Herlev, Denmark
[6] Sorlandet Hosp, Ctr Canc Treatment, Kristiansand, Norway
[7] Univ Oslo, Inst Clin Med, Oslo, Norway
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)30805-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0385
引用
收藏
页码：S192 / S193
页数：2
相关论文
共 50 条
  • [1] Outcome after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Staehelin, Annina
    Kern, Beatrice
    Guenin, Marc-Olivier
    Peterli, Ralph
    Ackermann, Christoph
    von Fluee, Markus
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (35-36) : 22S - 22S
  • [2] Adjuvant Chemotherapy after neoadjuvant Chemoradiotherapy for Rectal cancer
    Reibetanz, J.
    Germer, C. -T.
    [J]. CHIRURG, 2014, 85 (06): : 544 - 544
  • [3] Rectal cancer: Neoadjuvant chemoradiotherapy
    Roedel, Claus
    Hofheinz, Ralf
    Fokas, Emmanouil
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (04) : 629 - 639
  • [4] Angiogenic marker associated with resistance to neoadjuvant chemoradiotherapy in rectal cancer
    Kim, Hanjo
    Lee, Min Young
    Ahn, Tae Sung
    Yun, Jina
    Kim, Kyoungha
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang Cheol
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Park, Seong Kyu
    Lee, Kyu Taek
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    Park, Suk-Young
    Lee, Moon Soo
    Baek, Moo Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Angiogenic marker associated with resistance to neoadjuvant chemoradiotherapy in rectal cancer
    Duarte, J.
    Beeton-Kempen, N.
    Shoko, A.
    Serufuri, J. M.
    Cebon, J.
    Blackburn, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S156 - S157
  • [6] Risk factors of recurrence of rectal cancer after neoadjuvant chemoradiotherapy
    El Fadli, M.
    Yousra, B.
    Shawar Al Tamimi, N.
    Adjade, G.
    Essadi, I.
    Belbaraka, R.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S334 - S334
  • [7] Transanal Endoscopic Microsurgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Issa, Nidal
    Murninkas, Alejandro
    Schmilovitz-Weiss, Hemda
    Agbarya, Abed
    Powsner, Eldad
    [J]. JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2015, 25 (08): : 617 - 624
  • [8] Expression of Immune Phenotypes in Rectal Cancer after neoadjuvant Chemoradiotherapy
    Schnellhardt, S.
    Hirneth, J.
    Buettner-Herold, M.
    Daniel, C.
    Fietkau, R.
    Distel, L.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S150 - S151
  • [9] Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer
    Ozturk, Sonay K.
    Martinez, Cristina G.
    Mens, David
    Verhoef, Cornelis
    Tosetto, Miriam
    Sheahan, Kieran
    de Wilt, Johannes H. W.
    Hospers, Geke A. P.
    van de Velde, Cornelis J. H.
    Marijnen, Corrie A. M.
    van Der Post, Rachel S.
    Nagtegaal, Iris D.
    [J]. HISTOPATHOLOGY, 2024, 84 (06) : 935 - 946
  • [10] Prognostic value of neoadjuvant rectal score in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
    Caetano, A. C.
    Monteiro, J. C.
    Costa, C.
    Salgueiro, F. R.
    Pires, M. R.
    Monteiro, A. R.
    Paulo, J.
    Jacinto, P.
    Bonito, N.
    Sousa, G.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S539 - S539
12345